Sherie Morrison, Ph.D. - Ms. Morrison has an extensive background in academia and business. She is a full professor at UCLA and has been a world-renowned pioneer on recombinant antibody technology. Her accomplishments include developing techniques for the creation of chimeric antibodies and novel expression systems including polymeric antibodies and antibody fusion proteins.

Kote Chintalacharuvu, Ph.D. - Mr. Chintalacharuvu has worked for many years as a researcher at UCLA. He has developed antibody technology to treat infectious diseases. He is developing therapeutics to prevent and treat Otitis Media. He has served as a consultant to major biotech companies and has led major scientific symposia.

Manuel Penichet, M.D., Ph.D. - Mr. Penichet has worked for many years as a researcher at UCLA. He developed a family of antibody fusion proteins used in treating cancer and for brain targeting. He received the AmgeAward. He is a co-inventor of GAVAC™, a highly effective, widely-used vaccine against cattle ticks.

Doug Levinson, J.D., M.B.A. - Mr. Levinson studied biology at UC Berkeley and Oxford University. He practiced law for several years and was designated by the United States District Court as a Special Master in complex patent cases. He received an MBA from UCLA and became part-time faculty at UCLA's Graduate School of Management. He was a co-founder of boutique investment banking firm. He has served on various for-profit and non-profit boards and as a senior executive in public and private companies.